AMES, Iowa, Sept. 26 /PRNewswire-FirstCall/ -- BioForce Nanosciences,
Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc.
(OTC Bulletin Board: BFNH.OB), shipped five of its core technology Nano
eNabler(TM) molecular printing systems to customers in the U.S. and Canada
in the third quarter, the Company announced. Under its previously announced
product placement program, BioForce plans on shipping up to 20 Nano eNabler
systems to prestigious domestic and international biomedical and life
science research facilities by year end. In consideration of a license to
use the Nano eNabler system to research applications, the facilities agree
to provide BioForce with feedback on the performance and applications of
The BioForce Nano eNabler system prints tiny domains of biological
materials on surfaces with nanometer spatial precision. The BioForce
instrument prints biomaterial sample sizes ranging from one to 20 microns
-- about 20 billion times smaller than a drop of blood -- allowing
researchers to investigate the development of new biomedical applications.
"During May of this year BioForce installed four Nano eNabler systems,
two in the U.S. and two overseas. We have integrated a comprehensive
installation, training and follow-up support process for the Nano eNabler
technology, moving our customers through a short learning curve," said
Michael Lynch, Product Manager. "The three devices shipped in August have
been installed successfully and customer training completed. Two additional
units have shipped with installation planned for October."
"For the remainder of the year BioForce anticipates shipping an
additional eleven systems bringing this total to 20 Nano eNabler system
shipments for 2006," said Kerry Frey, BioForce Chief Operations Officer.
"Our manufacturing team is actively building systems to meet our
production goals," said Curtis Mosher, founder and Vice President of
Research and Development. "I am pleased with how the Company has integrated
the process encompassing inventory, build, installation, training and
About BioForce Nanosciences, Inc.
BioForce Nanosciences is a nanotechnology tools and applications
company, providing innovative and practical products that support the
growth of the nanotechnology industry. The Company has spent more than a
decade of invention, research and development on patented and
patent-pending nanotechnology products. The core technology is the Nano
eNabler(TM) benchtop molecular printer, a portal to new opportunities in
nanotechnology. The Nano eNabler system uses microfluidic surface
patterning tools to print biomaterials that are one to 20 microns in size.
The Nano eNabler system opens the door to new and important applications in
the biomedical and life sciences markets that lead to improved quality of
life. BioForce continues to target inventions that further expand the reach
of its proprietary technology and expand its robust patent, trademark and
BioForce Nanosciences, Inc., the Practical Nanotechnology(TM) Company,
brings inventions to the marketplace that complement existing innovations,
licensing and acquisitions. BioForce is a wholly owned subsidiary of
BioForce Nanosciences Holdings, Inc. (OTC Bulletin Board: BFNH.OB). For
more information, visit http://www.bioforcenano.com.
This news release contains forward-looking information that may be
affected by certain risks and uncertainties, including those risks and
uncertainties described in the Company's most recent filings with the
Securities and Exchange Commission. The Company's actual results could
differ materially from such forward-looking statements. We assume no duty
to update these statements at any future date.
SOURCE BioForce Nanosciences, Inc.